THE EFFECT OF ALVEOLAR RECRUITMENT MANOEUVRE ON INTRAOPERATIVE HAEMODYNAMICS

December 9, 2025 updated by: Ozlem Sagir, MD, Balikesir University
Alveolar recruitment manoeuvre plays a key role in the prevention of atelectasis. In addition, it affects haemodynamic parameters. This study aims to investigate the effects of RM on haemodynamic parameters using minimally invasive monitoring techniques.

Study Overview

Detailed Description

During laparoscopic hysterectomy, pneumoperitoneum is created with carbon dioxide (CO₂) to provide surgical field of view and the patient is placed in Trendelenburg position. This increases intrathoracic pressure, decreases lung compliance and increases the risk of atelectasis. Therefore, lung protective ventilation strategies such as alveolar recruitment manoeuvre (RM), individualised PEEP application and low tidal volume are recommended. RM aims to increase lung compliance and prevent atelectasis by reopening collapsed alveoli. However, changes in haemodynamic parameters, especially mean arterial pressure and cardiac output, may occur during RM. In addition to standard monitoring for the management of these changes, haemodynamic evaluation can be performed with minimally invasive methods such as arterial waveform analysis. In this study, we aimed to evaluate the effects of RM applied during laparoscopic hysterectomy on intraoperative haemodynamic parameters using arterial waveform analysis.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

  • ASA I-II risk group patients
  • Patients between 18-70 y undergoing laparoscopic hysterectomy surgery

Description

Inclusion Criteria:

  • ASA Class 1-2 patients 18-70 years old

Exclusion Criteria:

  • <18 y, BMI>40
  • Patients receiving invasive mechanical ventilator support in the last 1 month
  • Patients who have received chemotherapy or radiotherapy in the last 2 months
  • Those with severe lung disease (COPD, asthma, pulmonary infection, bronchiectasis, previous need for non-invasive mechanical ventilation, oxygen therapy or steroid therapy for acute attack)
  • Known severe pulmonary hypertension
  • Patient refusal to participate in the study
  • Intracranial tumour
  • Haemodynamic instability
  • Shock
  • Neuromuscular disease
  • Pathologies causing increased intracranial and intraocular pressure
  • Atrial fibrillation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Alveolar Recruitment Maneuver Applied
Alveolar Recruitment Maneuver Not Applied

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of RM on heart rate (in bpm)
Time Frame: perioperatively
measurement of heart rate in bpm
perioperatively
Effect of RM on pressure mmHg
Time Frame: perioperatively
blood pressure measurement in mmmercury
perioperatively
Effect of RM on Cardiac index(CI)
Time Frame: intraoperatively
Cardiac Index measurement via an arterial cannula as l/min/m2
intraoperatively
Effect of RM on stroke volume index(SVI)
Time Frame: intraoperatively
SVI measurement via arterial cannula as L/min/m2
intraoperatively
Effect of RM on pulse pressure variablity(PPV)
Time Frame: intraoperatively
pulse pressure variability measured by finger probe as cm/s
intraoperatively
Effect of RM on systemic vascular resistance index(SVRI)
Time Frame: intraoperatively
systemic vascular resistance index(SVRI) measurement via arterial cannula as L/min/m2
intraoperatively
Effect of RM on cardiac power index(CPI)
Time Frame: intraoperatively
cardiac power index(CPI) measurement via arterial line as ml/min/m2
intraoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of RM on Compliance
Time Frame: intraoperatively
measurement of dynamic compliance by Ventilator as Cdyn
intraoperatively
Effect of RM on Oxygenation
Time Frame: İntraoperatively
measurement of oxygenation via obtaining partial blood oxygene pressure via arterial blood sample pulse oxymeter as %
İntraoperatively
Postoperative pulmonary comlications (infection, bronchospasm, pleural effusion, atelectasis, respiratory failure)
Time Frame: postoperative day 1 and 3
assessment of pulmonary complications
postoperative day 1 and 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ahmet Koroglu, Professor, medical doctor, Balikesir University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2023

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 15, 2023

Study Registration Dates

First Submitted

April 9, 2025

First Submitted That Met QC Criteria

December 9, 2025

First Posted (Actual)

December 23, 2025

Study Record Updates

Last Update Posted (Actual)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 9, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • BalikesirU OSagır 001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laparoscopic Hysterectomy

Subscribe